Health
Existing drug masitinib identified as potential inhibitor of SARS-CoV-2 – News-Medical.Net
Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COV…
Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
The drug, which is called masitinib, potently inhibited the main viral protease 3CLpro that SARs-CoV-2 relies on for infection to proceed once the viral genome has entered the host cell cytoplasm.
The study showed that masitinib di…
-
General22 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business22 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General24 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General23 hours agoHow a fake expert crashed the World | The West Report